Common Stock	9 Months Ended
Apr. 30, 2019
Equity [Abstract]
Common Stock	During the year ended July 31, 2018, the Company sold 16,559,000 shares of common stock for total cash proceeds of $219,475; $20,000 of which had not yet been received as of July 31, 2018. The $20,000 was received in the quarter ended October 31, 2018. In addition, 1,000,000 shares of those sold were not issued as of July 31, 2018 and have therefore been credited to common stock to be issued. The 1,000,000 shares were issued in February 2019. During the nine months ended April 30, 2019, the Company issued 150,000 shares of common stock to two individuals as consideration for their support with the Richey #2A project. The shares were valued at $0.065 per share, the closing price on the date of grant, for total non-cash expense of $9,750. During the nine months ended April 30, 2019, the Company sold 1,000,000 Units of its common stock for total cash proceeds of $50,000. Each Unit consists of one common share and one-half share purchase warrant exercisable for 2 years. Each whole share purchase warrant has an exercise price of $0.15 per common share. During the nine months ended April 30, 2019, the Company sold 4,166,667 shares of common stock for total cash proceeds of $145,000. As of April 30, 2019, 400,000 shares have not yet been issued by the transfer agent and have therefore been credited to common stock to be issued.

Common Stock

9 Months Ended

Apr. 30, 2019

During the year ended July 31, 2018, the Company sold 16,559,000 shares of common stock for total cash proceeds of $219,475; $20,000 of which had not yet been received as of July 31, 2018. The $20,000 was received in the quarter ended October 31, 2018. In addition, 1,000,000 shares of those sold were not issued as of July 31, 2018 and have therefore been credited to common stock to be issued. The 1,000,000 shares were issued in February 2019.

During the nine months ended April 30, 2019, the Company issued 150,000 shares of common stock to two individuals as consideration for their support with the Richey #2A project. The shares were valued at $0.065 per share, the closing price on the date of grant, for total non-cash expense of $9,750.

During the nine months ended April 30, 2019, the Company sold 1,000,000 Units of its common stock for total cash proceeds of $50,000. Each Unit consists of one common share and one-half share purchase warrant exercisable for 2 years. Each whole share purchase warrant has an exercise price of $0.15 per common share.

During the nine months ended April 30, 2019, the Company sold 4,166,667 shares of common stock for total cash proceeds of $145,000. As of April 30, 2019, 400,000 shares have not yet been issued by the transfer agent and have therefore been credited to common stock to be issued.